BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 17304653)

  • 1. Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab.
    Kaine JL; Kivitz AJ; Birbara C; Luo AY
    J Rheumatol; 2007 Feb; 34(2):272-9. PubMed ID: 17304653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine responses in patients with rheumatoid arthritis treated with certolizumab pegol: results from a single-blind randomized phase IV trial.
    Kivitz AJ; Schechtman J; Texter M; Fichtner A; de Longueville M; Chartash EK
    J Rheumatol; 2014 Apr; 41(4):648-57. PubMed ID: 24584918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept.
    Alten R; Bingham CO; Cohen SB; Curtis JR; Kelly S; Wong D; Genovese MC
    BMC Musculoskelet Disord; 2016 May; 17():231. PubMed ID: 27229685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.
    Bingham CO; Looney RJ; Deodhar A; Halsey N; Greenwald M; Codding C; Trzaskoma B; Martin F; Agarwal S; Kelman A
    Arthritis Rheum; 2010 Jan; 62(1):64-74. PubMed ID: 20039397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab.
    van Assen S; Holvast A; Benne CA; Posthumus MD; van Leeuwen MA; Voskuyl AE; Blom M; Risselada AP; de Haan A; Westra J; Kallenberg CG; Bijl M
    Arthritis Rheum; 2010 Jan; 62(1):75-81. PubMed ID: 20039396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of belimumab on vaccine antigen antibodies to influenza, pneumococcal, and tetanus vaccines in patients with systemic lupus erythematosus in the BLISS-76 trial.
    Chatham WW; Wallace DJ; Stohl W; Latinis KM; Manzi S; McCune WJ; Tegzová D; McKay JD; Avila-Armengol HE; Utset TO; Zhong ZJ; Hough DR; Freimuth WW; Migone TS;
    J Rheumatol; 2012 Aug; 39(8):1632-40. PubMed ID: 22707609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors.
    Kapetanovic MC; Roseman C; Jönsson G; Truedsson L; Saxne T; Geborek P
    Arthritis Rheum; 2011 Dec; 63(12):3723-32. PubMed ID: 21834061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.
    Kapetanovic MC; Saxne T; Sjöholm A; Truedsson L; Jönsson G; Geborek P
    Rheumatology (Oxford); 2006 Jan; 45(1):106-11. PubMed ID: 16287919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response.
    Oren S; Mandelboim M; Braun-Moscovici Y; Paran D; Ablin J; Litinsky I; Comaneshter D; Levartovsky D; Mendelson E; Azar R; Wigler I; Balbir-Gurman A; Caspi D; Elkayam O
    Ann Rheum Dis; 2008 Jul; 67(7):937-41. PubMed ID: 17981914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response to influenza vaccine and pneumococcal polysaccharide vaccine under IL-6 signal inhibition therapy with tocilizumab.
    Tsuru T; Terao K; Murakami M; Matsutani T; Suzaki M; Amamoto T; Nakashima H; Akiyama A; Nishimoto N
    Mod Rheumatol; 2014 May; 24(3):511-6. PubMed ID: 24252023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis.
    Elkayam O; Bashkin A; Mandelboim M; Litinsky I; Comaheshter D; Levartovsky D; Mendelson E; Wigler I; Caspi D; Paran D
    Semin Arthritis Rheum; 2010 Jun; 39(6):442-7. PubMed ID: 19246078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
    Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
    J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults ≥50years of age: Results from a phase III, randomized, non-inferiority trial.
    Ofori-Anyinam O; Leroux-Roels G; Drame M; Aerssens A; Maes C; Amanullah A; Schuind A; Li P; Jain VK; Innis BL
    Vaccine; 2017 Nov; 35(46):6321-6328. PubMed ID: 28987445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients.
    Migita K; Akeda Y; Akazawa M; Tohma S; Hirano F; Ideguchi H; Kozuru H; Jiuchi Y; Matsumura R; Suematsu E; Miyamura T; Mori S; Fukui T; Izumi Y; Iwanaga N; Tsutani H; Saisyo K; Yamanaka T; Ohshima S; Mori N; Matsumori A; Takahi K; Yoshizawa S; Kawabe Y; Suenaga Y; Ozawa T; Hamada N; Komiya Y; Matsui T; Furukawa H; Oishi K
    Arthritis Res Ther; 2015 Dec; 17():357. PubMed ID: 26653668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab.
    Arad U; Tzadok S; Amir S; Mandelboim M; Mendelson E; Wigler I; Sarbagil-Maman H; Paran D; Caspi D; Elkayam O
    Vaccine; 2011 Feb; 29(8):1643-8. PubMed ID: 21211590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFalpha blockers: safety and immunogenicity.
    Salemi S; Picchianti-Diamanti A; Germano V; Donatelli I; Di Martino A; Facchini M; Nisini R; Biselli R; Ferlito C; Podestà E; Cappella A; Milanetti F; Rossi F; Amodeo R; Tabacco F; Di Rosa R; Laganà B; D Amelio R
    Clin Immunol; 2010 Feb; 134(2):113-20. PubMed ID: 19846344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone.
    Visvanathan S; Keenan GF; Baker DG; Levinson AI; Wagner CL
    J Rheumatol; 2007 May; 34(5):952-7. PubMed ID: 17444589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy.
    Hanania NA; Sockrider M; Castro M; Holbrook JT; Tonascia J; Wise R; Atmar RL;
    J Allergy Clin Immunol; 2004 Apr; 113(4):717-24. PubMed ID: 15100679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older.
    Kerzner B; Murray AV; Cheng E; Ifle R; Harvey PR; Tomlinson M; Barben JL; Rarrick K; Stek JE; Chung MO; Schödel FP; Wang WW; Xu J; Chan IS; Silber JL; Schlienger K
    J Am Geriatr Soc; 2007 Oct; 55(10):1499-507. PubMed ID: 17908055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.